About: http://webisa.webdatacommons.org/146748781

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	However, advances are being made in elucidating SSc and other CTDs, and there are now options available to target certain aspects of disease, particularly vasculopathic manifestations, with agents such as ET receptor antagonists.
http://www.w3.org/ns/prov#wasQuotedFrom	nih.gov